BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PYVOBJECT//NONSGML Version 1//EN
BEGIN:VTIMEZONE
TZID:Europe/Berlin
BEGIN:STANDARD
DTSTART:20001029T030000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=10
TZNAME:CET
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20000326T020000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3
TZNAME:CEST
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
UID:20260522T184937Z - 52479@eupv422
DTSTART;TZID=Europe/Berlin:20260407T090000
DTEND;TZID=Europe/Berlin:20260409T180000
CREATED:20260522T184937Z
DESCRIPTION:<a href="https://www.knauer.net/event/5th-lnp-formulation-proce
 ss-development-us-summit-95/register">5th LNP Formulation & Process Develo
 pment US Summit</a>\nVisit KNAUER at 5th LNP Formulation & Process Develop
 ment Summit in Boston! As the LNP field continues to expand\, from mRNA va
 ccines to cutting-edge cell and gene therapies\, the 5th LNP Formulation &
  Process Development Summit returns to Boston in April 2026. Curated in co
 llaboration our Scientific Advisory Board\, Annette Bak (AstraZeneca)\, Lu
 is Brito (Beam Therapeutics)\, and Ching Kim Tye (Sanofi)\, this premier f
 orum is designed to deliver LNP-specific networking and knowledge sharing.
  Join LNP innovators to advance extrahepatic targeting\, stable formulatio
 n design\, robust analytical characterization\, and consistent large-scale
  manufacturing to accelerate LNP-based therapeutics to the market.
DTSTAMP:20260522T184937Z
LOCATION:The Westin Boston Seaport District\, 425 Summer ST\, Boston  MA022
 10\, United States
SUMMARY:5th LNP Formulation & Process Development US Summit
X-ALT-DESC;FMTTYPE=text/html:<a href="https://www.knauer.net/event/5th-lnp-
 formulation-process-development-us-summit-95/register">5th LNP Formulation
  & Process Development US Summit</a>\nVisit KNAUER at 5th LNP Formulation 
 & Process Development Summit in Boston! As the LNP field continues to expa
 nd\, from mRNA vaccines to cutting-edge cell and gene therapies\, the 5th 
 LNP Formulation & Process Development Summit returns to Boston in April 20
 26. Curated in collaboration our Scientific Advisory Board\, Annette Bak (
 AstraZeneca)\, Luis Brito (Beam Therapeutics)\, and Ching Kim Tye (Sanofi)
 \, this premier forum is designed to deliver LNP-specific networking and k
 nowledge sharing. Join LNP innovators to advance extrahepatic targeting\, 
 stable formulation design\, robust analytical characterization\, and consi
 stent large-scale manufacturing to accelerate LNP-based therapeutics to th
 e market.
END:VEVENT
END:VCALENDAR